Purification method of prothrombin complex

The DEAE A-50 gel was pretreated by using the combined structure of the outer filter assembly and the inner filter assembly and the aqueous ammonium acetate solution during the purification of the prothrombin complex, and the problem of insufficient filter shedding and adsorption capacity was solved, and the problem of the filter shedding and adsorption capacity was achieved. Efficient PCC purification and yield improvement.

CN118956835AInactive Publication Date: 2024-11-15YIGE PHARMA HUNAN PROV
View PDF 15 Cites 0 Cited by

Patent Information

Application Number
CN202411449626.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-17
Publication Date
2024-11-15
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

During the purification process of existing prothrombin complex (PCC), traditional filtration methods cause the filter to fall off or rupture, affecting the quality of the filtrate, and the adsorption capacity of the DEAE A-50 gel is insufficient, affecting PCC Yield and purity.

Method used

Using a combined structure of outer filter assembly and inner filter assembly, the filter screen is designed to prevent the filter screen from falling off, and the DEAE A-50 gel is pretreated by aqueous ammonium acetate solution to replace the chloride ions on the gel and increase the Hydroxide ion concentration improves the adsorption capacity and elution efficiency of the gel.

Benefits of technology

It effectively avoids the filter shedding and rupture, improves the yield and purity of PCC, enhances the adsorption and elution speed, and improves the production efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118956835A_ABST
    Figure CN118956835A_ABST
Patent Text Reader

Abstract

The invention provides a purification method of a prothrombin complex, which comprises the following steps: raw material filtration, S / D inactivation and dilution, gel pretreatment, column packing by using pretreated DEAE A-50 for fixed bed column chromatography, ultrafiltration concentration, liquid preparation filtration, split charging and freeze-drying to obtain a purified finished product of the prothrombin complex. The filtering tank is used for filtering raw materials after slurry mixing, a filter screen is prevented from falling off and being broken in the filtering process, the treatment efficiency of the raw materials is improved, meanwhile, swelling A-50 gel is pretreated through an ammonium acetate aqueous solution, the adsorption capacity and adsorption strength of sol to acidic protein are improved, the product purity is guaranteed, and meanwhile the product quality is improved. The adsorption and washing speed can be properly improved, so that the yield is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of prothrombin purification, in particular to a method for purifying a prothrombin complex. Background Art

[0002] Prothrombin complex (PCC) is separated and extracted from fresh plasma of healthy people. It is a mixed preparation containing coagulation factors II, VII, IX, X and a small amount of other plasma proteins. It is mainly used to prevent and treat bleeding caused by the deficiency of coagulation factors II, VII, IX and X, such as bleeding caused by hemophilia B, severe liver disease, disseminated intravascular coagulation and surgery. With the gradual clinical recognition, the use of PCC has increased year by year, but the current PCC production is low and there is a serious shortage. Its production and preparation has attracted attention from all parties.

[0003] However, when preparing PCC, plasma needs to be filtered to remove large molecular insoluble impurities. In traditional filtration methods, as the thickness of the filter cake accumulates, the filter plate will fall off or break, causing a large amount of impurities to enter the filtrate, affecting the quality of the filtrate. At the same time, the traditional use of DEAE A-50 gel to directly adsorb, wash and desorb PCC in the filtrate only uses the gel's own pores and weakly alkaline groups for adsorption, which affects the total amount of PCC adsorption and the resolution is not high, affecting the yield and purity of PCC. Summary of the invention

[0004] 1. Technical issues to be resolved

[0005] In view of the deficiencies of the prior art, the present invention provides a method for purifying a prothrombin complex to solve the problems raised in the above background technology.

[0006] (II) Technical solution

[0007] To achieve the above object, the present invention is implemented by the following technical scheme: a method for purifying a prothrombin complex, comprising the following steps:

[0008] S1. Removal of plasma cryoprecipitate: fresh refrigerated plasma is used as raw material, and the raw material is melted, mixed, and filtered to obtain a coarse filtrate;

[0009] An outer filter assembly is installed at the feed port of the filter tank, and an inner filter assembly is installed inside the outer filter assembly. The outer filter assembly includes a filter screen, and the inner filter assembly includes a filter plate. The raw materials after slurry mixing are put into the filter tank. After the materials are filtered by the filter plate and the filter screen, the coarse filtrate is discharged from the outlet at the lower end of the filter tank. The filter cake remaining on the upper surface of the filter plate pushes the filter plate to deform, so that the outer filter assembly approaches the upper end surface of the inner filter assembly, and the edge of the filter screen is clamped to prevent the filter screen from falling off during the filtration process, affecting the filtration effect.

[0010] S2, S / D inactivation and dilution: Slowly add the prepared S / D inactivation solution to the coarse filtrate under gentle stirring, and stir for 30 minutes after adding; adjust the liquid temperature to 24-26℃, and inactivate for 6 hours; after inactivation, add diluent to dilute and reduce the conductivity value to 800-1000us to obtain sterile dilution;

[0011] S3, gel pretreatment: DEAE A-50 dry gel and distilled water were weighed at a ratio of 1:100, and the DEAE A-50 dry gel was suspended in distilled water. After 1 hour, the upper fine particles were removed to obtain swollen A-50. The swollen A-50 was immersed in an ammonium acetate solution at a concentration of 15 ml / g of 0.5N ammonium acetate for DEAE A-50 dry gel, stirred well, and allowed to stand for 30 minutes. The pretreated A-50 was filtered to obtain the pretreated A-50, and the treated pretreated A-50 was immersed in a 0.5N ammonium acetate solution for storage;

[0012] S4, fixed bed column chromatography: pre-treated A-50 is loaded into a fixed bed chromatography column, and the loaded chromatography column is balanced with a balance solution for 2-5 column volumes, and a peristaltic pump chromatography column is used for the sterile diluent, and the loading flow rate is 40-50 cm / h; after the loading is completed, a washing solution is pumped into the chromatography column for online flushing, and the washing solution flow rate is 40-50 cm / h, and the flushing time is 40-60 min; the washed chromatography column is pumped into the eluent for elution using a peristaltic pump, and the eluent flow rate is 30-40 cm / h. When the ultraviolet absorption value in the online ultraviolet detector is lower than 500 Au, the elution is stopped, and the eluent is collected and filtered using a 0.45 um filter element to obtain a prothrombin complex extract;

[0013] S5, ultrafiltration and concentration: using dialysate to perform ultrafiltration and dialysis on the prothrombin complex extract, and then performing ultrafiltration and concentration after the conductivity value of the dialysate port is lower than 1000us to obtain a prothrombin complex concentrate;

[0014] S6. Liquid preparation: Use dialysate to dilute the prothrombin complex concentrate, adjust the activity to 30-40 IU / ml, pH 7-7.5, filter using a 0.45 um filter, package, and freeze-dry to obtain the purified prothrombin complex product.

[0015] As a further preference, the outer layer filter assembly in S1 includes an L-shaped limiting ring that is clamped at the feed port of the filter tank, the lower end face of the L-shaped limiting ring is fixedly connected to an elastic connecting net, the end of the elastic connecting net that is away from the L-shaped limiting ring is fixedly connected to a mounting ring, the open end of the filter screen is fixedly connected to the inner wall of the mounting ring, and the closed end of the filter screen extends through the lower end of the mounting ring.

[0016] As a further preferred embodiment, in S1, the inner filter assembly is installed on the inner wall of the filter screen, and the inner filter assembly includes a fixed ring that is clamped on the inner wall of the filter tank, and a plurality of groups of air outlet holes are spaced apart on the inner wall of the fixed ring. A ventilation pipe is fixedly connected to the side wall of the fixed ring, and the ventilation pipe extends upward from the feed port of the filter tank to be connected to the air supply device, and a plurality of groups of air outlet holes are connected to the ventilation pipe, and the filter plate is fixedly connected to the lower end surface of the fixed ring.

[0017] As a further preference, the fixing ring in S1 is made of elastic material such as latex, plastic, etc., and the inside of the fixing ring is hollow.

[0018] As a further preference, the filter plate in S1 is a medicinal PE or polyethylene filter plate, and the filter screen is a medicinal cellulose filter screen.

[0019] As a further preference, in S3, filter paper or cellulose filter plate with a diameter of 80-120 mm is used, and an oil-free vacuum pump is used for filtration, with a vacuum degree of 0.03 MPa.

[0020] As a further preference, the washing solution in S4 consists of 0.015 mol / L sodium citrate and 0.15 mol / L sodium chloride, with a pH of 7.0-7.2; the eluent consists of 7.5-15 mmol / L sodium citrate and 2.4 mol / L sodium chloride, with a pH of 6.6-6.8.

[0021] (III) Beneficial effects

[0022] The present invention provides a method for purifying a prothrombin complex, which has the following beneficial effects:

[0023] The present invention filters the raw materials after the slurry is mixed through the filter tank, and the raw materials are filtered through the filter plate and the filter screen, and the filtrate flows out through the lower end of the filter tank, and the filter cake is deposited on the upper surface of the filter plate. As the filtering proceeds, the accumulation of the filter cake causes the filter plate to deform downward, and the deformed filter plate pushes the filter screen to move downward. When the filter screen moves, it drives the mounting ring to stretch the elastic connecting net to approach the fixing ring, and the lower end surface of the mounting ring and the upper end surface of the air outlet clamp the edge of the filter screen to prevent the filter screen from falling off during the filtering process. At the same time, the pressure of the filter cake is buffered by the deformation of the elastic connecting net to prevent the filter screen from breaking. When the thickness of the filter cake reaches a certain degree, air is blown into the ventilation pipe through the air supply device, and the air flow is blown to the upper surface of the filter plate through the air outlet to destroy the filter cake, so as to prevent the filter cake from being too thick and affecting the filtering speed. After the filtering is completed or the amount of filter cake accumulation is too large, the entire filter cake and the filter assembly can be taken out by holding the L-shaped limiting ring, which is convenient for cleaning the filter cake.

[0024] Moreover, by pretreating the swollen A-50 gel with an aqueous solution of ammonium acetate, the hydroxide ions in the solution replace the chloride ions on the gel, and the consumption of the hydroxide ions promotes the further hydrolysis of the ammonium ions, thereby generating more hydroxide ions. The hydroxide ions and the porosity and adsorption of the A-50 gel itself work synergistically to increase the adsorption amount and adsorption strength of the acidic protein. While ensuring the purity of the product, the adsorption and washing speeds can be appropriately increased to increase the yield.

[0025] Finally, the hydroxide ions in the washed gel column are neutralized by a weakly acidic high-salt eluent to reduce the adsorption of hydroxide ions on PCC. At the same time, PCC is replaced by positive and negative ions rich in high salt, thereby separating PCC from the gel and achieving the purpose of rapid elution. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 is a flow chart of the method for purifying the prothrombin complex of the present invention;

[0027] Figure 2 It is a schematic diagram of the cross-sectional structure of the filter tank of the present invention;

[0028] Figure 3 It is a schematic diagram of the structure of the outer filter assembly of the present invention;

[0029] Figure 4 It is a schematic diagram of the structure of the inner filter assembly of the present invention;

[0030] Figure 5 This is the elution curve diagram of the experimental group 1 of the present invention;

[0031] Figure 6 This is the elution curve diagram of experimental group 2 of the present invention;

[0032] Figure 7 This is the elution curve diagram of the experimental group 3 of the present invention;

[0033] Figure 8 This is the elution curve diagram of Comparative Example 1 of the present invention;

[0034] Fig. 9 It is the elution curve diagram of Comparative Example 2 of the present invention.

[0035] In the figure: 1 filter tank, 2 outer filter assembly, 21 L-shaped limit ring, 22 mounting ring, 23 filter screen, 24 elastic connecting net, 3 inner filter assembly, 31 ventilation pipe, 32 fixing ring, 33 air outlet, 34 filter plate. DETAILED DESCRIPTION

[0036] The embodiments of the present invention are described in detail below, and examples of the embodiments are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements having the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are only used to explain the present invention, and cannot be understood as limiting the present invention.

[0037] In the present invention, unless otherwise clearly specified and limited, a first feature being "above" or "below" a second feature may include that the first and second features are in direct contact, or may include that the first and second features are not in direct contact but are in contact through another feature between them. Moreover, a first feature being "above", "above" and "above" a second feature includes that the first feature is directly above and obliquely above the second feature, or simply indicates that the first feature is higher in level than the second feature. A first feature being "below", "below" and "below" a second feature includes that the first feature is directly below and obliquely below the second feature, or simply indicates that the first feature is lower in level than the second feature.

[0038] The disclosure below provides many different embodiments or examples to implement different structures of the present invention. In order to simplify the disclosure of the present invention, the parts and settings of specific examples are described below. Of course, they are only examples, and the purpose is not to limit the present invention. In addition, the present invention can repeat reference numbers and / or reference letters in different examples, and this repetition is for the purpose of simplicity and clarity, which itself does not indicate the relationship between the various embodiments and / or settings discussed. In addition, the present invention provides various specific examples of processes and materials, but those of ordinary skill in the art can appreciate the application of other processes and / or the use of other materials.

[0039] like Figure 1 As shown, an embodiment of the present invention provides a method for purifying a prothrombin complex, comprising the following steps:

[0040] S1. Removal of plasma cryoprecipitate: fresh refrigerated plasma is used as raw material, and the raw material is melted, mixed, and filtered to obtain a coarse filtrate;

[0041] An outer filter assembly 2 is installed at the feed port of the filter tank 1, and an inner filter assembly 3 is installed inside the outer filter assembly 2. The outer filter assembly 2 includes a filter screen 23, and the inner filter assembly 3 includes a filter plate 34. The raw materials after slurry mixing are put into the filter tank 1. After the materials are filtered by the filter plate 34 and the filter screen 23, the coarse filtrate is discharged from the discharge port at the lower end of the filter tank 1. The filter cake remaining on the upper end surface of the filter plate 34 pushes the filter plate 34 to deform, so that the outer filter assembly 2 approaches the upper end surface of the inner filter assembly 3, and the edge of the filter screen 23 is clamped to prevent the filter screen 23 from falling off during the filtration process, which affects the filtration effect.

[0042] S2, S / D inactivation and dilution: Slowly add the prepared S / D inactivation solution to the coarse filtrate under gentle stirring, and stir for 30 minutes after adding; adjust the liquid temperature to 24-26℃, and inactivate for 6 hours; after inactivation, add diluent to dilute and reduce the conductivity value to 800-1000us to obtain sterile dilution;

[0043] The diluent is specifically a 0.1 mol / l sodium chloride aqueous solution, Ph7.0.

[0044] S3, gel pretreatment: DEAE A-50 dry gel and distilled water were weighed at a ratio of 1:100, and the DEAE A-50 dry gel was suspended in distilled water. After 1 hour, the upper fine particles were removed to obtain swollen A-50. The swollen A-50 was immersed in an ammonium acetate solution at a concentration of 15 ml / g of 0.5N ammonium acetate for DEAE A-50 dry gel, stirred well, and allowed to stand for 30 minutes. The pretreated A-50 was filtered to obtain the pretreated A-50, and the treated pretreated A-50 was immersed in a 0.5N ammonium acetate solution for storage;

[0045] Among them, the filtration adopts 80-120mm filter paper or cellulose filter plate, and uses an oil-free vacuum pump for filtration, and the vacuum degree is 0.03MPa.

[0046] S4, fixed bed column chromatography: pre-treated A-50 is loaded into a fixed bed chromatography column, and the loaded chromatography column is balanced with a balance solution for 2-5 column volumes, and a peristaltic pump chromatography column is used for the sterile diluent, and the loading flow rate is 40-50 cm / h; after the loading is completed, a washing solution is pumped into the chromatography column for online flushing, and the washing solution flow rate is 40-50 cm / h, and the flushing time is 40-60 min; the washed chromatography column is pumped into the eluent for elution using a peristaltic pump, and the eluent flow rate is 30-40 cm / h. When the ultraviolet absorption value in the online ultraviolet detector is lower than 500 Au, the elution is stopped, and the eluent is collected and filtered using a 0.45 um filter element to obtain a prothrombin complex extract;

[0047] The washing solution is composed of 0.015 mol / L sodium citrate and 0.15 mol / L sodium chloride, with a pH of 7.0-7.2; the eluent is composed of 7.5-15 mmol / L sodium citrate and 2.4 mol / L sodium chloride, with a pH of 6.6-6.8;

[0048] S5, ultrafiltration and concentration: using dialysate to perform ultrafiltration and dialysis on the prothrombin complex extract, and then performing ultrafiltration and concentration after the conductivity value of the dialysate port is lower than 1000us to obtain a prothrombin complex concentrate;

[0049] S6. Liquid preparation: Use dialysate to dilute the prothrombin complex concentrate, adjust the activity to 30-40 IU / ml, pH 7-7.5, filter using a 0.45 um filter, package, and freeze-dry to obtain the purified prothrombin complex product.

[0050] In order to further understand the present invention, a method for purifying a prothrombin complex provided by the present invention is described below in conjunction with examples, and the protection scope of the present invention is not limited by the following examples.

[0051] Example 1

[0052] The prothrombin complex was purified using plasma as a raw material by the above purification method. The process conditions of each control group are shown in Table 1:

[0053] Table 1 is a table of the purification process of prothrombin complex in experimental group 1, experimental group 2 and experimental group 3

[0054] Example 2

[0055] The present invention also provides a plasma filtration device, comprising a filtration tank 1, an outer layer filtration component 2 and an inner layer filtration component 3.

[0056] See also Figures 2 to 4 A feed port is provided at the top of the filter tank 1, a discharge port is provided at the bottom of the filter tank 1, a card slot is provided on the inner wall of the filter tank 1, an outer filter component 2 is installed at the feed port of the filter tank 1, the lower end of the outer filter component 2 extends to the inner cavity of the filter tank 1, the inner filter component 3 is installed inside the outer filter component 2, and is installed in the card slot by card connection, the raw material enters from the feed port at the top of the filter tank 1, is filtered by the inner filter component 3 and the outer filter component 2, and the coarse filtrate is discharged from the discharge port.

[0057] Specifically, the outer filter assembly 2 includes an L-shaped limiting ring 21 clamped on the edge of the feed port, the lower end face of the L-shaped limiting ring 21 is fixedly connected to an elastic connecting net 24, the end of the elastic connecting net 24 facing away from the L-shaped limiting ring 21 is fixedly connected to a mounting ring 22, the inner wall of the mounting ring 22 is fixedly connected to the open end of the filter screen 23, the closed end of the filter screen 23 passes through the mounting ring 22 and extends out of the lower end face of the mounting ring 22, the inner filter assembly 3 includes a fixing ring 32 clamped in the slot, the lower end face of the fixing ring 32 is fixedly connected to a filter plate 34, a plurality of groups of air outlet holes 33 are spaced apart on the inner wall of the fixing ring 32, a ventilation pipe 31 is fixedly connected to the inner wall of the fixing ring 32, and the upper end of the ventilation pipe 31 extends out of the inner cavity of the filter tank 1 and is connected to the air outlet end of the air supply device.

[0058] It should be added that the outer diameter of the mounting ring 22 is equal to the inner diameter of the filter tank 1, the outer diameter of the fixing ring 32 is equal to the inner diameter of the slot, the fixing ring 32 is hollow inside, and the fixing ring 32 is an elastic material that does not react with the raw material, such as latex, plastic, etc.

[0059] The filter screen 23 is then moved by the external force, and the mounting ring 22 and the fixing ring 22 are pulled closer to each other to press the edge of the filter screen 23, and the pressing force increases with the increase of the impact force of the filtrate and the filter cake, thereby further preventing the filter screen 23 from falling off during the filtration process.

[0060] Comparative Example 1

[0061] S1. Removal of plasma cryoprecipitate: fresh refrigerated plasma is used as raw material, and the raw material is melted, mixed, and filtered to obtain a coarse filtrate;

[0062] S2, S / D inactivation and dilution: Slowly add the prepared S / D inactivation solution to the coarse filtrate under gentle stirring, and stir for 30 minutes after adding; adjust the liquid temperature to 24-26℃, and inactivate for 6 hours; after inactivation, add diluent to dilute and reduce the conductivity value to 800-1000us to obtain sterile dilution;

[0063] The diluent is specifically a 0.1 mol / l sodium chloride aqueous solution, Ph7.0.

[0064] S3, gel pretreatment: DEAE A-50 dry gel and distilled water were weighed at a ratio of 1:100, and the DEAE A-50 dry gel was suspended in distilled water. After 1 hour, the upper fine particles were removed to obtain swollen A-50. The swollen A-50 was immersed in an ammonium acetate solution at a concentration of 15 ml / g of 0.5N ammonium acetate for DEAE A-50 dry gel, stirred well, and allowed to stand for 30 minutes. The pretreated A-50 was filtered to obtain the pretreated A-50, and the treated pretreated A-50 was immersed in a 0.5N ammonium acetate solution for storage;

[0065] Among them, the filtration adopts 80-120mm filter paper or cellulose filter plate, and uses an oil-free vacuum pump for filtration, and the vacuum degree is 0.03MPa.

[0066] S4, fixed bed column chromatography: pre-treated A-50 is loaded into a fixed bed chromatography column, and the loaded chromatography column is balanced with a balance solution for 2-5 column volumes, and a peristaltic pump chromatography column is used for the sterile diluent, and the loading flow rate is 50 cm / h; after the loading is completed, a washing solution is pumped into the chromatography column for online flushing, and the washing solution flow rate is 50 cm / h, and the flushing time is 60 min; the washed chromatography column is pumped into the eluent for elution using a peristaltic pump, and the eluent flow rate is 40 cm / h. When the ultraviolet absorption value in the online ultraviolet detector is lower than 500 Au, the elution is stopped, and the eluent is collected and filtered using a 0.45 um filter element to obtain a prothrombin complex extract;

[0067] The washing solution is composed of 0.015 mol / L sodium citrate and 0.15 mol / L sodium chloride, with a pH of 7.0-7.2; the eluent is composed of 7.5-15 mmol / L sodium citrate and 2.4 mol / L sodium chloride, with a pH of 6.6-6.8;

[0068] S5, ultrafiltration and concentration: using dialysate to perform ultrafiltration and dialysis on the prothrombin complex extract, and then performing ultrafiltration and concentration after the conductivity value of the dialysate port is lower than 1000us to obtain a prothrombin complex concentrate;

[0069] S6. Liquid preparation: dilute the prothrombin complex concentrate with dialysate, adjust the activity to 30-40 IU / ml, pH 7-7.5, filter with a 0.45 um filter, package, and freeze-dry to obtain the purified prothrombin complex product of Comparative Example 1.

[0070] Comparative Example 2

[0071] S1. Removal of plasma cryoprecipitate: fresh refrigerated plasma is used as raw material, and the raw material is melted, mixed, and filtered to obtain a coarse filtrate;

[0072] An outer filter assembly 2 is installed at the feed port of the filter tank 1, and an inner filter assembly 3 is installed inside the outer filter assembly 2. The outer filter assembly 2 includes a filter screen 23, and the inner filter assembly 3 includes a filter plate 34. The raw materials after slurry mixing are put into the filter tank 1. After the materials are filtered by the filter plate 34 and the filter screen 23, the coarse filtrate is discharged from the discharge port at the lower end of the filter tank 1. The filter cake remaining on the upper end surface of the filter plate 34 pushes the filter plate 34 to deform, so that the outer filter assembly 2 approaches the upper end surface of the inner filter assembly 3, and the edge of the filter screen 23 is clamped to prevent the filter screen 23 from falling off during the filtration process, which affects the filtration effect.

[0073] S2, S / D inactivation and dilution: Slowly add the prepared S / D inactivation solution to the coarse filtrate under gentle stirring, and stir for 30 minutes after adding; adjust the liquid temperature to 24-26℃, and inactivate for 6 hours; after inactivation, add diluent to dilute and reduce the conductivity value to 800-1000us to obtain sterile dilution;

[0074] S3, gel pretreatment: weigh DEAE A-50 dry gel and distilled water at a ratio of 1:100, suspend DEAE A-50 dry gel in distilled water, and remove the upper fine particles after 1 hour to obtain swollen A-50;

[0075] S4, fixed bed column chromatography: the swollen A-50 is loaded into a fixed bed chromatography column, and the loaded chromatography column is balanced with a balance solution for 2-5 column volumes, and the sterile diluent is used for the chromatography column using a peristaltic pump, and the loading flow rate is 50 cm / h; after the loading is completed, a washing solution is pumped into the chromatography column using a peristaltic pump for online flushing, and the washing solution flow rate is 50 cm / h, and the flushing time is 60 min; the washed chromatography column is pumped into the eluent for elution using a peristaltic pump, and the eluent flow rate is 40 cm / h. When the ultraviolet absorption value in the online ultraviolet detector is lower than 500 Au, the elution is stopped, and the eluent is collected and filtered using a 0.45 um filter element to obtain a prothrombin complex extract;

[0076] The washing solution is composed of 0.015 mol / L sodium citrate and 0.15 mol / L sodium chloride, with a pH of 7.0-7.2; the eluent is composed of 7.5-15 mmol / L sodium citrate and 2.4 mol / L sodium chloride, with a pH of 6.6-6.8;

[0077] S5, ultrafiltration and concentration: using dialysate to perform ultrafiltration and dialysis on the prothrombin complex extract, and then performing ultrafiltration and concentration after the conductivity value of the dialysate port is lower than 1000us to obtain a prothrombin complex concentrate;

[0078] S6. Liquid preparation: dilute the prothrombin complex concentrate with dialysate, adjust the activity to 30-40 IU / ml, pH 7-7.5, filter with a 0.45 um filter, package, and freeze-dry to obtain the purified prothrombin complex product of Comparative Example 2.

[0079] Performance Testing:

[0080] The target protein in the crude filtrate and prothrombin complex concentrate was quantitatively analyzed by Coomassie brilliant blue staining colorimetry.

[0081] Yield = crude prothrombin complex / refined prothrombin complex * 100%

[0082] Specific data are shown in Table 2:

[0083] Table 2 is a statistical table of the results of experimental group 1, experimental group 2, experimental group 3, comparative example 1 and comparative example 2

[0084] In summary, the present invention filters the raw material after mixing through the filter tank 1, and the raw material is filtered through the filter plate 34 and the filter screen 23. The filtrate flows out through the lower end of the filter tank 1, and the filter cake is deposited on the upper end surface of the filter plate 34. As the filtering proceeds, the filter cake accumulates and causes the filter plate 34 to deform downward. The deformed filter plate 34 pushes the filter screen 23 to move downward. When the filter screen 23 moves, it drives the mounting ring 22 to stretch the elastic connecting net 24 to approach the fixing ring 32. The lower end surface of the mounting ring 22 and the upper end surface of the air outlet 33 clamp the edge of the filter screen 23 to prevent the filter screen 23 from falling off during the filtering process. At the same time, the pressure of the filter cake passes through The elastic connecting net 24 is deformed for buffering to avoid the rupture of the filter screen 23, thereby improving the efficiency and capacity of continuous filtration. At the same time, the swollen A-50 gel is pretreated with an aqueous ammonium acetate solution, and the hydroxide ions in the solution replace the chloride ions on the gel. The consumption of the hydroxide ions promotes the further hydrolysis of the ammonium ions, thereby generating more hydroxide ions. The hydroxide ions and the porosity and adsorption of the A-50 gel themselves work synergistically to increase the adsorption amount and adsorption strength of the acidic protein. While ensuring the purity of the product, the adsorption and washing speeds can be appropriately increased to increase the yield.

[0085] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A method for purifying a prothrombin complex, comprising the following steps: S1. Removal of plasma cryoprecipitate: fresh refrigerated plasma is used as raw material, and the raw material is melted, mixed, and filtered to obtain a coarse filtrate; S2, S / D inactivation and dilution: Slowly add the prepared S / D inactivation solution to the coarse filtrate under gentle stirring, and stir for 30 minutes after adding; adjust the liquid temperature to 24-26℃, and inactivate for 6 hours; after inactivation, add diluent to dilute and reduce the conductivity value to 800-1000us to obtain sterile dilution; S3, gel pretreatment: DEAE A-50 dry gel and distilled water were weighed at a ratio of 1:100, and the DEAE A-50 dry gel was suspended in distilled water. After 1 hour, the upper fine particles were removed to obtain swollen A-50. The swollen A-50 was immersed in an ammonium acetate solution at a concentration of 15 ml / g of 0.5N ammonium acetate for DEAE A-50 dry gel, stirred well, and allowed to stand for 30 minutes. The pretreated A-50 was filtered to obtain the pretreated A-50, and the treated pretreated A-50 was immersed in a 0.5N ammonium acetate solution for storage; S4, fixed bed column chromatography: pre-treated A-50 is loaded into a fixed bed chromatography column, and the loaded chromatography column is balanced with a balance solution for 2-5 column volumes, and a peristaltic pump chromatography column is used for the sterile diluent, and the loading flow rate is 40-50 cm / h; after the loading is completed, a washing solution is pumped into the chromatography column for online flushing, and the washing solution flow rate is 40-50 cm / h, and the flushing time is 40-60 min; the washed chromatography column is pumped into the eluent for elution using a peristaltic pump, and the eluent flow rate is 30-40 cm / h. When the ultraviolet absorption value in the online ultraviolet detector is lower than 500 Au, the elution is stopped, and the eluent is collected and filtered using a 0.45 um filter element to obtain a prothrombin complex extract; S5, ultrafiltration and concentration: using dialysate to perform ultrafiltration and dialysis on the prothrombin complex extract, and then performing ultrafiltration and concentration after the conductivity value of the dialysate port is lower than 1000us to obtain a prothrombin complex concentrate; S6. Liquid preparation: Use dialysate to dilute the prothrombin complex concentrate, adjust the activity to 30-40 IU / ml, pH 7-7.5, filter using a 0.45 um filter, package, and freeze-dry to obtain the purified prothrombin complex product.

2. The method for purifying a prothrombin complex according to claim 1, characterized in that: The filtration in S1 uses a filter tank, the feed port of the filter tank is installed with an outer filter component, the inner filter component is installed inside the outer filter component, the outer filter component includes a filter screen, the inner filter component includes a filter plate, and the filter screen and the filter plate are both used for filtration.

3. The method for purifying a prothrombin complex according to claim 2, characterized in that: The outer filter assembly includes an L-shaped limiting ring that is clamped on the feed port of the filter tank, the lower end face of the L-shaped limiting ring is fixedly connected to an elastic connecting net, the end of the elastic connecting net that is away from the L-shaped limiting ring is fixedly connected to a mounting ring, the open end of the filter screen is fixedly connected to the inner wall of the mounting ring, and the closed end of the filter screen extends through the lower end of the mounting ring.

4. The method for purifying a prothrombin complex according to claim 3, characterized in that: The inner filter assembly is installed on the inner wall of the filter screen, and the inner filter assembly includes a fixed ring that is clamped on the inner wall of the filter tank. A plurality of groups of air outlet holes are spaced apart on the inner wall of the fixed ring. A ventilation pipe is fixedly connected to the side wall of the fixed ring. The ventilation pipe extends upward from the feed port of the filter tank and is connected to the air supply device. A plurality of groups of air outlet holes are connected to the ventilation pipe, and the filter plate is fixedly connected to the lower end surface of the fixed ring.

5. The method for purifying prothrombin complex according to claim 4, characterized in that: The fixing ring is made of elastic materials such as latex and plastic, and the inside of the fixing ring is hollow.

6. The method for purifying a prothrombin complex according to claim 5, characterized in that: The filter plate is a medicinal PE or polyethylene filter plate, and the filter screen is a medicinal cellulose filter screen.

7. The method for purifying a prothrombin complex according to claim 1, characterized in that: The filtration in S3 is specifically carried out by using 80-120 mm filter paper or cellulose filter plate and an oil-free vacuum pump, and the vacuum degree is 0.03 MPa.

8. The method for purifying prothrombin complex according to claim 1, characterized in that: The washing solution in S4 is composed of 0.015 mol / L sodium citrate and 0.15 mol / L sodium chloride, with a pH of 7.0-7.2; the eluent is composed of 7.5-15 mmol / L sodium citrate and 2.4 mol / L sodium chloride, with a pH of 6.6-6.8.

Citation Information

Patent Citations

  • Method for preparing human prothrombin complex with high yield

    CN102614219A

  • Method for adsorbing human prothrombin complex from plasma

    CN104109202A

  • Method for preparing human prothrombin complex from plasma

    CN106676089A

  • Blood coagulation filtering device for hemodialysis, venous tube and hemodialysis device

    CN113289106A

  • Multi-stage filtering device for traditional Chinese medicine extraction for protecting cardiovascular system

    CN118767507A